SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

CELU

Celularity Inc.
NASDAQHealth Care

Latest close: 1.25 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record◆Adverse 8-K filing◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Sep 29, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  2. Sep 29, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗
  3. Sep 28, 2026Material event · 8-KFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record52417 flagged findings
Reported transactions (Form 4)80since Dec 19, 2024 · and 11 other holdings
Corporate events (8-K)30since Aug 1, 2025

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-09-29share offering or dilution eventfreshOpen filing ↗
    “…convertible notes. We issued a Senior Secured Non-Convertible Promissory Note of $7.0 million (the “Senior Note”) and a warrant to…”
    +1 more passage from the same document
    • “…to purchase up to 2,448,917 shares of our Class A common stock (the “Senior Note Warrant”). On February 13, 2026, we repaid in…”
  • 2026-09-29listing compliance noticefreshOpen filing ↗
    “…with Nasdaq Listing Rule 5550(b)(2) due to its market value of listed securities falling below the $ 35 million threshold for…”
    +1 more passage from the same document
    • “…7, 2026 to regain compliance with this requirement. On July 23, 2026, Nasdaq additionally notified the Company of non-compliance…”
  • 2026-09-29regulatory investigationfreshOpen filing ↗
    “…after first Commercial Sale of a Licensed Product. In addition, the Sirion License is subject to termination rights including for…”
    +1 more passage from the same document
    • “…In addition, the Sirion License is subject to termination rights including for termination for material breach and by the Company…”
  • 2026-09-28share offering or dilution eventfreshOpen filing ↗
    “…gross cash proceeds of approximately $11.01 million, before fees and expenses, together with Warrants initially exercisable…”
    +1 more passage from the same document
    • “…Equity Securities. Financing The information set forth under Item 1.01 of this Current Report on Form 8-K concerning the Purchase…”
  • 2025-05-21share offering or dilution eventolderOpen filing ↗
    “…Tranche 2 Warrant issued to RWI, dated as of January 16, 2024 (incorporated by reference to Exhibit 10.7 to the current report on…”
    +1 more passage from the same document
    • “…February 16, 2024, pursuant to which Dr. Hariri will be paid the $1.088 million if we raise additional cash through offerings of…”
  • 2025-05-21merger or acquisition eventolderOpen filing ↗
    “…2024, between Celularity Inc. and Resorts World Inc Pte Ltd (incorporated by reference to Exhibit 10.8 to the current report on…”
    +1 more passage from the same document
    • “…to Exhibit 10.8 to the current report on Form 8-K, filed on January 17, 2024). 10.32¥ Agreement and Plan of Merger, dated August…”
  • 2025-05-21reverse splitolderOpen filing ↗
    “…fair market value price of our Class A common stock on the date of grant. Annual grants to our executive officers are comprised of…”
    +1 more passage from the same document
    • “…to the fair market value price of our Class A common stock on the date of grant. Annual grants to our executive officers are…”

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

Reverse splits in 5 years

1 reverse split in 5 years (1:10 on Feb 29, 2024) · 1:10 cumulative

The other times: of 818 securities that did their first reverse split in 5 years, a year later the median was worth 0.53× the price on the day of the split; 382 lost more than half and 209 rose (809 with a price a year later).

Our own series, not the whole market: based on the splits we have on record (provider and SEC); an unrecorded one does not count. Historical distribution, not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 524)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Sep 29, 268-K ↗Current report · A senior executive left or was appointed
  • Sep 29, 2610-Q ↗Quarterly report
  • Sep 28, 268-K ↗Current report · Entered a material agreement
  • Sep 28, 26SCHEDULE 13D/A ↗Stake with intent to influence · PHILIP & DANIELE BARACH FAMILY TRUST · 29.0% · event on Sep 23, 26 · amendment
  • Insider transaction · 3 Form 4 filingsshow all 3hide
  • Sep 14, 268-K ↗Current report · Other events
  • Aug 14, 26NT 10-Q ↗Late filing notice
  • Aug 7, 268-K ↗Current report · A senior executive left or was appointed
  • Jul 29, 268-K ↗Current report · Listing notice (8-K 3.01)
  • Jul 22, 2625-NSE ↗Delisting or deregistration
  • Jun 30, 268-K ↗Current report · Entered a material agreement
  • Jun 25, 268-K ↗Current report · A senior executive left or was appointed
  • Insider transaction · 3 Form 4 filingsshow all 3hide
  • Jun 23, 26SCHEDULE 13D/A ↗Stake with intent to influence · PHILIP & DANIELE BARACH FAMILY TRUST · 15.8% · event on Jun 19, 26 · amendment
  • Jun 12, 268-K ↗Current report · Listing notice (8-K 3.01)
  • Jun 3, 268-K ↗Current report · A senior executive left or was appointed
  • May 28, 268-K ↗Current report · Entered a material agreement
  • May 15, 26NT 10-Q ↗Late filing notice
  • Apr 30, 2610-K ↗Annual report
  • Insider transaction · 2 Form 3 filingsshow all 2hide

524 filings on record, the oldest from Nov 29, 18.

Listing the 25 most recent filings of the 524 on record.

8-Ks, explained

Stress11Structure77Governance32
  • Sep 29, 26GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Sep 28, 26StructureEntered a material agreement+4 more in the same filing8-K 1.01 ↗
  • Aug 7, 26GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Jul 29, 26StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Jun 30, 26StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Jun 25, 26GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Jun 12, 26StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Jun 3, 26GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Structure3 material agreements entered2026show all 3hide
    • May 28, 26StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
    • Apr 21, 26StructureEntered a material agreement+5 more in the same filing8-K 1.01 ↗
    • Mar 10, 26StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Mar 5, 26GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Jan 21, 26GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Dec 23, 25StructureTook on a new financial obligation+4 more in the same filing8-K 2.03 ↗

4 older filings not shown · The record reaches back to May 24, 19.

Notable in the record

Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.

The full record holds 11 stress filings.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13D: stake and stated purpose

Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.

  • Lim Kok Thay41.0%Jul 24, 25SCHEDULE 13D/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum.
  • Genting Berhad36.4%Jan 24, 25SCHEDULE 13D/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • PHILIP & DANIELE BARACH FAMILY TRUST29.0%Sep 23, 26SCHEDULE 13D/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings
  • PHILP & DANIELE BARACH FAMILY TRUST9.6%Dec 19, 25SCHEDULE 13D ↗3 co-filers on this document — the figure is the largest single stake, not their sum.

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • Lincoln Alternative Strategies LLC5.1%Jul 14, 25SCHEDULE 13G ↗
  • BRISTOL MYERS SQUIBB CO1.9%Dec 31, 24SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum.

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

No purchases or sales are on record in this stretch; only other transactions (compensation, withholding, exercises or gifts).

Stock compensation, tax and giftsshow the 40 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Apr 13, 26Compensationamount n/aRobert J HaririChief Executive Officer↗
  • Apr 13, 26Tax$2KRobert J HaririChief Executive Officer↗
  • Apr 13, 26Compensationamount n/aJohn R HainesSenior Exec Vice President↗
  • Apr 13, 26Tax$746John R HainesSenior Exec Vice President↗
  • Apr 13, 26Compensationamount n/aStephen BrigidoPres., Functional Regeneration↗
  • Apr 13, 26Tax$343Stephen BrigidoPres., Functional Regeneration↗
  • Jan 12, 26Compensationamount n/aDiane L. Parks↗
  • Jan 12, 26Compensationamount n/aPeter Diamandis↗
  • Jan 12, 26Compensationamount n/aVincent LeVien↗
  • Jan 12, 26Compensationamount n/aGeoffrey Ling M.D.↗
  • Dec 29, 25Compensationamount n/aPeter Diamandis↗
  • Dec 29, 25Compensationamount n/aDiane L. Parks↗
  • Dec 29, 25Compensationamount n/aGeoffrey Ling M.D.↗
  • Dec 29, 25Compensationamount n/aVincent LeVien↗
  • Dec 19, 25Compensationamount n/aPeter Diamandis↗
  • Dec 19, 25Compensationamount n/aGeoffrey Ling M.D.↗
  • Dec 19, 25Compensationamount n/aDiane L. Parks↗
  • Nov 19, 25Compensationamount n/aPeter Diamandis↗
  • Nov 19, 25Compensationamount n/aGeoffrey Ling M.D.↗
  • Nov 19, 25Compensationamount n/aVincent LeVien↗
  • Nov 19, 25Compensationamount n/aDiane L. Parks↗
  • Apr 13, 25Compensationamount n/aDavid C BeersChief Financial Officer↗
  • Apr 13, 25Tax$590David C BeersChief Financial Officer↗
  • Apr 13, 25Compensationamount n/aStephen BrigidoPres., Functional Regeneration↗
  • Apr 13, 25Tax$440Stephen BrigidoPres., Functional Regeneration↗
  • Apr 13, 25Compensationamount n/aJohn R HainesSenior Exec Vice President↗
  • Apr 13, 25Tax$946John R HainesSenior Exec Vice President↗
  • Apr 13, 25Compensationamount n/aRobert J HaririChief Executive Officer↗
  • Apr 13, 25Tax$2KRobert J HaririChief Executive Officer↗
  • Feb 17, 25Compensationamount n/aJohn R HainesSenior Exec Vice President↗
  • Feb 17, 25Tax$15KJohn R HainesSenior Exec Vice President↗
  • Feb 17, 25Compensationamount n/aDavid C BeersChief Financial Officer↗
  • Feb 17, 25Tax$9KDavid C BeersChief Financial Officer↗
  • Feb 17, 25Compensationamount n/aStephen BrigidoPres., Functional Regeneration↗
  • Feb 17, 25Tax$7KStephen BrigidoPres., Functional Regeneration↗
  • Jan 24, 25Other$1.1MKok Thay Lim↗
  • Jan 24, 25Other$1.4MKok Thay Lim↗
  • Dec 19, 24Compensationamount n/aRICHARD J BERMAN↗
  • Dec 19, 24Compensationamount n/aPeter Diamandis↗
  • Dec 19, 24Compensationamount n/aDean C Kehler↗

The full record holds 84 transactions and goes back to Feb 10, 23.

Its sector and its market

Celularity Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Celularity Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Celularity Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
Series with incidents in the period; the chart shows what could be kept.
SEC records
524 documents on file, from Nov 29, 2018 to Sep 29, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.